Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
15.1%
% of SBIO's 87 holdings also in CANC
28.9%
% of CANC's 45 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 3.1% | 3.1% | 3.1% |
|
CELLDEX THERAPEUTICS INC | 1.7% | 2.6% | 1.7% |
 |
MERUS N.V. | 1.6% | 1.7% | 1.6% |
|
INTELLIA THERAPEUTICS, INC. | 1.6% | 1.8% | 1.6% |
|
ARVINAS, INC. | 1.8% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to CANC
|
VIKING THERAPEUTICS, INC. | 5.3% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | 4.8% |
|
VAXCYTE, INC. | 4.6% |
 |
ALKERMES PLC | 2.8% |
|
AXSOME THERAPEUTICS, INC. | 2.3% |
|
CRINETICS PHARMACEUTICALS INC | 2.1% |
|
XENON PHARMACEUTICALS INC. | 2.0% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.8% |
|
DENALI THERAPEUTICS INC. | 1.7% |
SBIO Underweight Relative to CANC
|
MERCK & CO. INC. | -5.6% |
|
REGENERON PHARMACEUTICALS | -5.6% |
 |
DAIICHI SANKYO CO LTD | -4.0% |
 |
ASTRAZENECA PLC | -3.8% |
|
NOVARTIS AG | -3.7% |
|
ILLUMINA INC | -3.5% |
|
EXACT SCIENCES CORP | -3.1% |
 |
ARGENX SE ADR | -2.9% |
|
GILEAD SCIENCES INC | -2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | -2.7% |